axillary
PURPOSE: In 1989, the National Surgical Adjuvant Breast and Bowel Project       initiated the B-22 trial to determine whether intensifying or intensifying and       increasing the total dose of cyclophosphamide in a doxorubicin-cyclophosphamide       combination would benefit women with primary breast cancer and positive axillary        nodes.
PURPOSE: In 1989, the National Surgical Adjuvant Breast and Bowel Project       initiated the B-22 trial to determine whether intensifying or intensifying and       increasing the total dose of cyclophosphamide in a doxorubicin-cyclophosphamide       combination would benefit women with primary breast cancer and positive  @SUBJECT$  @PREDICAT$  @OBJECT$ .